Companies · Investment Vehicle
San Francisco · Investment Vehicle · refined from filed group “Other Health Care”
Diligence memoA one-page analyst read on PNC Co-Investor Holding Company, LLC — recommendation, valuation, rhythm, risks.→PNC Co-Investor Holding Company, LLC has raised $3.3M over 3 rounds; too few niche peers to rank its valuation yet.
Synthesized from the figures below est. — every claim rests on a number shown on this page.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
PNC Co-Investor Holding Company, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
PNC Co-Investor Holding Company, LLC is one of 1793 Investment Vehicle companies tracked from San Francisco. By capital raised it ranks mid-pack (ahead of 51% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.
Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks. Directional, not a quoted figure.
Benchmarked against 1793 companies in Investment Vehicle. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 51% of sector peers (real $). Modeled value above 4% of peers (estimate).
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Pre-Seed | $973K | 2021-11-26 | $5.4M | $12.2M | 90% |
| Seed | $2.5M | 2021-11-26 | $12.3M | $27.1M | 90% |
| Seed | $1.1M | 2021-11-26 | $5.4M | $11.8M | 90% |
| Seed | $700K | 2023-08-23 | $3.5M | $4.0M | 90% |
| Seed | $188K | 2024-04-16 | $938K | $852K | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Mark deLaar | — | 3 other | 2023-08 |
| Alexander Reyzelman | — | 1 other | 2023-08 |
| Chris Roussos | — | 1 other | 2023-08 |
| Corey Golde | — | 1 other | 2023-08 |
| Kevin Offel | — | 1 other | 2023-08 |
| Lowell, Jr. Weil | — | 1 other | 2023-08 |
| Mark Shankar | — | 1 other | 2023-08 |
| Stephen Pohlmeyer | — | 1 other | 2021-11 |
| Thomas Elardo | — | 1 other | 2023-08 |
PNC Co-Investor Holding Company, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| PNC Podiatry Holdings, LLC | Other Health Care | Seed | $3.6M | $911K | network9 shared operators · same stage |
| eClinical Solutions LLC | Other Technology | Series B | $19.3M | $586.3M | network1 shared operator |
| Modernizing Medicine, Inc. | Other | Series D+ | $341.0M | $725.7M | network1 shared operator |
See where PNC Co-Investor Holding Company, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at PNC Co-Investor Holding Company, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.